Integrated Diagnostics (LON:IDHC) Shares Cross Below 50-Day Moving Average – Should You Sell?

Integrated Diagnostics Holdings plc (LON:IDHC)’s share price crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 0.67 and traded as low as GBX 0.63. Integrated Diagnostics shares last traded at GBX 0.66, with a volume of 47,264 shares.

Integrated Diagnostics Price Performance

The stock’s 50-day moving average price is GBX 0.67 and its 200 day moving average price is GBX 0.60. The company has a quick ratio of 0.75, a current ratio of 1.59 and a debt-to-equity ratio of 45.72. The firm has a market capitalization of £3.84 million, a price-to-earnings ratio of 0.00, a PEG ratio of 7.65 and a beta of 0.59.

Integrated Diagnostics Company Profile

IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests.